#Bristol Myers Squibb
-

AstraZeneca-Bristol Myers Merger Talks Stir Doubts Over $400 Billion Pharma Deal
Reported merger talks between AstraZeneca and Bristol Myers Squibb have put a potential $400 billion pharmaceutical deal on investors’ radar.…